Canaccord Genuity Maintains Hold on Immunocore Hldgs, Raises Price Target to $67
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Bill Maughan maintains a Hold rating on Immunocore Holdings (IMCR) and raises the price target from $63 to $67.
May 09, 2024 | 6:53 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Canaccord Genuity maintains a Hold rating on Immunocore Holdings and increases the price target from $63 to $67.
The increase in price target by Canaccord Genuity suggests a positive outlook on the stock's value, potentially leading to increased investor interest and a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100